Abbott Labs has spun off its specialty drug division into a new company called AbbVie, which the new company's leaders heralded Wednesday by ringing the first opening bell of 2013 at the New York Stock Exchange.
The Food and Drug Administration has approved a supplemental new drug application related to a drug made by Abbott, the company said.